001 | 137535 | ||
005 | 20240321220252.0 | ||
024 | 7 | _ | |a 10.1016/j.physbeh.2014.05.041 |2 doi |
024 | 7 | _ | |a pmid:24907698 |2 pmid |
024 | 7 | _ | |a 0031-9384 |2 ISSN |
024 | 7 | _ | |a 1873-507X |2 ISSN |
024 | 7 | _ | |a altmetric:2421448 |2 altmetric |
037 | _ | _ | |a DZNE-2020-03857 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Schneider, F. |0 P:(DE-2719)2810406 |b 0 |e First author |u dzne |
245 | _ | _ | |a Behavioral and EEG changes in male 5xFAD mice. |
260 | _ | _ | |a Amsterdam [u.a.] |c 2014 |b Elsevier Science |
264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2014-08-01 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1705667703_6325 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Transgenic animal models of Alzheimer's disease (AD) are widely used to investigate mechanisms of pathophysiology and cognitive dysfunctions. A model with a very early development of parenchymal plaque load at the age of 2months is the 5xFAD mouse (Tg6799, Oakley et al. 2006). These 5xFAD mice over-express both human amyloid precursor protein (APP) and human presenilin 1 (PS1). Mice from this line have a high APP expression correlating with a high burden and an accelerated accumulation of the 42 amino acid species of amyloid-β (Aβ). The aim of this study was the behavioral and functional investigations of 5xFAD males because in most studies females of this strain were characterized. In comparison to literature of transgenic 5xFAD females, transgenic 5xFAD males showed decreased anxiety in the elevated plus maze, reduced locomotion and exploration in the open field and disturbances in learning performance in the Morris water maze starting at 9months of age. Electroencephalogram (EEG) recordings on 6month old transgenic mice revealed a decrease of delta, theta, alpha, beta and gamma frequency bands whereas the subdelta frequency was increased. EEG recordings during sleep showed a reduction of rapid eye movement sleep in relation to the amount of total sleep. Thus, 5xFAD males develop early functional disturbances and subsequently behavioral deficits and therefore they are a good mouse model for studying Alzheimer's disease. |
536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
542 | _ | _ | |i 2014-08-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 7 | |a Amyloid beta-Protein Precursor |2 NLM Chemicals |
650 | _ | 7 | |a PSEN1 protein, human |2 NLM Chemicals |
650 | _ | 7 | |a Presenilin-1 |2 NLM Chemicals |
650 | _ | 2 | |a Alzheimer Disease: genetics |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: physiopathology |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: psychology |2 MeSH |
650 | _ | 2 | |a Amyloid beta-Protein Precursor: genetics |2 MeSH |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a Anxiety: genetics |2 MeSH |
650 | _ | 2 | |a Anxiety: physiopathology |2 MeSH |
650 | _ | 2 | |a Anxiety: psychology |2 MeSH |
650 | _ | 2 | |a Behavior, Animal: physiology |2 MeSH |
650 | _ | 2 | |a Brain: physiopathology |2 MeSH |
650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
650 | _ | 2 | |a Electroencephalography |2 MeSH |
650 | _ | 2 | |a Exploratory Behavior: physiology |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Maze Learning: physiology |2 MeSH |
650 | _ | 2 | |a Mice |2 MeSH |
650 | _ | 2 | |a Mice, Transgenic |2 MeSH |
650 | _ | 2 | |a Presenilin-1: genetics |2 MeSH |
650 | _ | 2 | |a Sleep: physiology |2 MeSH |
700 | 1 | _ | |a Baldauf, K. |0 P:(DE-2719)2239681 |b 1 |e Corresponding author |u dzne |
700 | 1 | _ | |a Wetzel, W. |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Reymann, Klaus |0 P:(DE-2719)2740485 |b 3 |e Last author |u dzne |
773 | 1 | 8 | |a 10.1016/j.physbeh.2014.05.041 |b : Elsevier BV, 2014-08-01 |p 25-33 |3 journal-article |2 Crossref |t Physiology & Behavior |v 135 |y 2014 |x 0031-9384 |
773 | _ | _ | |a 10.1016/j.physbeh.2014.05.041 |g Vol. 135, p. 25 - 33 |0 PERI:(DE-600)2008755-X |q 135<25 - 33 |p 25-33 |t Physiology & behavior |v 135 |y 2014 |x 0031-9384 |
856 | 4 | _ | |u https://pub.dzne.de/record/137535/files/DZNE-2020-03857_Restricted.pdf |
856 | 4 | _ | |u https://pub.dzne.de/record/137535/files/DZNE-2020-03857_Restricted.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:pub.dzne.de:137535 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2810406 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2239681 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2740485 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
914 | 1 | _ | |y 2014 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b PHYSIOL BEHAV : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0130 |2 StatID |b Social Sciences Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1180 |2 StatID |b Current Contents - Social and Behavioral Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 1 | _ | |0 I:(DE-2719)1310005 |k AG Reymann |l Pathophysiology of Dementia |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1340016 |k Core MR PET |l Core MR PET |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1310005 |
980 | _ | _ | |a I:(DE-2719)1340016 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|